MyFinsight
Home
Blog
About
Proceeds from issuance of
note payable, net
$205K
(-70.16%↓ Y/Y)
Net cash provided by
financing activities -...
$67K
(-97.00%↓ Y/Y)
Canceled cashflow
$138K
Net cash provided by
financing activities
$67K
(-96.95%↓ Y/Y)
Repayment of note payable
$138K
(-94.50%↓ Y/Y)
Decrease in cash and cash
equivalents
-$11K
(97.84%↑ Y/Y)
Canceled cashflow
$67K
Net cash used in
operating activities
-$78K
(97.85%↑ Y/Y)
Accounts payable and
accrued expenses
$1,172K
(161.61%↑ Y/Y)
Depreciation and
amortization
$963K
(-65.98%↓ Y/Y)
Amortization of debt discount
$760K
(-10.48%↓ Y/Y)
Stock-based compensation
expense
$375K
(-63.56%↓ Y/Y)
Loss from investment
in unconsolidated...
-$47K
Prepaid expenses and
other current assets
-$37K
(-104.61%↓ Y/Y)
Lease liabilities
$32K
(210.34%↑ Y/Y)
Change in fair value of
derivative liability
-$13K
Net cash used in
operating activities -...
-$78K
(98.15%↑ Y/Y)
Canceled cashflow
$3,399K
Loss from continuing
operations after income...
-$3,051K
(66.66%↑ Y/Y)
Debt extinguishment
loss
$398K
(155.43%↑ Y/Y)
Deferred revenue
-$15K
(96.34%↑ Y/Y)
Other liabilities
-$11K
(96.86%↑ Y/Y)
Income tax payable
-$2K
(99.67%↑ Y/Y)
Back
Back
Cash Flow
ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (PRPH)
source: myfinsight.com